Tina Hahn, who joined AXON in 2012 as Vice President, will now take on the role of AXON’s President and Managing Partner.

Eli Lilly and Creyon Bio have entered into a partnership worth over $1bn to develop RNA-targeted oligonucleotide (oligo) ...

AbbVie’s Rinvoq (upadacitinib) has been approved by the US Food and Drug Administration (FDA) to treat adults with giant cell ...

Cog 4: Keep learning a priority With heavy workloads, it’s easy for learning to fall down the list. To prevent this, ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that a fixed-duration regimen of Calquence ...

Our brains are quick to process visual information, rapidly recognizing familiar objects or scenarios and spotting ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorisation to Autolus ...

Learn more about gen Z: who they are, where they can be reached and how they like to be engaged and find out Say’s five tips ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD30-directed antibody-drug conjugate (ADC ...

The phase 3 CREST trial has been assessing the subcutaneously-administered drug in combination with standard-of-care Bacillus ...

The answer is yes, pharma can have an impact We can and should use our expertise and resources to tackle misinformation.

Generics account for 81% of U.K. primary care prescriptions but just 28% of NHS medicines spending, delivering significant ...